Insider Trading Alert - CKEC, GWRE And WMGI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 18, 2015, 93 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $500.00 to $575,784,180.28.

Highlighted Stocks Traded by Insiders:

Carmike Cinemas (CKEC) - FREE Research Report

Passman S David Iii, who is President and CEO at Carmike Cinemas, sold 40,000 shares at $29.01 on May 18, 2015. Following this transaction, the President and CEO owned 199,207 shares meaning that the stake was reduced by 16.72% with the 40,000-share transaction.

Hare Richard B, who is SVP-Finance, Treasurer and CFO at Carmike Cinemas, sold 22,560 shares at $28.83 on May 18, 2015. Following this transaction, the SVP-Finance, Treasurer and CFO owned 57,312 shares meaning that the stake was reduced by 28.25% with the 22,560-share transaction.

The shares most recently traded at $28.80, down $0.03, or 0.1% since the insider transaction. Historical insider transactions for Carmike Cinemas go as follows:

  • 4-Week # shares bought: 169
  • 4-Week # shares sold: 40,000
  • 12-Week # shares bought: 169
  • 12-Week # shares sold: 40,000
  • 24-Week # shares bought: 169
  • 24-Week # shares sold: 40,000

The average volume for Carmike Cinemas has been 302,300 shares per day over the past 30 days. Carmike Cinemas has a market cap of $720.4 million and is part of the services sector and media industry. Shares are up 12.49% year-to-date as of the close of trading on Monday.

Carmike Cinemas, Inc., together with its subsidiaries, operates as a motion picture exhibitor in the United States. The company operates digital cinema and 3-D cinema theatres that show films on a first-run basis; and discount theatres primarily serving mid-size non-urban markets. Currently, there are 8 analysts who rate Carmike Cinemas a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CKEC - FREE

TheStreet Quant Ratings rates Carmike Cinemas as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, poor profit margins and a generally disappointing performance in the stock itself. Get the full Carmike Cinemas Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Guidewire Software (GWRE) - FREE Research Report

Conway Craig, who is Director at Guidewire Software, sold 1,000 shares at $49.60 on May 18, 2015. Following this transaction, the Director owned 10,414 shares meaning that the stake was reduced by 8.76% with the 1,000-share transaction.

The shares most recently traded at $49.93, up $0.33, or 0.65% since the insider transaction. Historical insider transactions for Guidewire Software go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 14,112
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 93,733

The average volume for Guidewire Software has been 335,000 shares per day over the past 30 days. Guidewire Software has a market cap of $3.5 billion and is part of the technology sector and computer software & services industry. Shares are down 1.28% year-to-date as of the close of trading on Monday.

Guidewire Software, Inc. provides software products for property and casualty (P&C) insurers. It offers an integrated suite of software applications that address the core processes, such as underwriting and policy administration, claims management, and billing. The company has a P/E ratio of 176.2. Currently, there are 4 analysts who rate Guidewire Software a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on GWRE - FREE

TheStreet Quant Ratings rates Guidewire Software as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, expanding profit margins and solid stock price performance. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Guidewire Software Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Wright Medical Group (WMGI) - FREE Research Report

Tracy Julie D, who is SVP & Chief Commun. Officer at Wright Medical Group, sold 1,120 shares at $26.10 on May 18, 2015. Following this transaction, the SVP & Chief Commun. Officer owned 12,090 shares meaning that the stake was reduced by 8.48% with the 1,120-share transaction.

Lightman James, who is SVP, General Counsel & Secty at Wright Medical Group, sold 1,178 shares at $26.10 on May 18, 2015. Following this transaction, the SVP, General Counsel & Secty owned 19,927 shares meaning that the stake was reduced by 5.58% with the 1,178-share transaction.

Girin Pascal E R, who is EVP & Chief Operating Officer at Wright Medical Group, sold 3,821 shares at $26.13 on May 18, 2015. Following this transaction, the EVP & Chief Operating Officer owned 39,162 shares meaning that the stake was reduced by 8.89% with the 3,821-share transaction.

Griffin William L. Jr, who is SVP GM BioMimetic Therapeutics at Wright Medical Group, sold 1,322 shares at $26.07 on May 18, 2015. Following this transaction, the SVP GM BioMimetic Therapeutics owned 68,995 shares meaning that the stake was reduced by 1.88% with the 1,322-share transaction.

Berry Lance A, who is Sr. VP & CFO at Wright Medical Group, sold 1,675 shares at $26.13 on May 18, 2015. Following this transaction, the Sr. VP & CFO owned 66,704 shares meaning that the stake was reduced by 2.45% with the 1,675-share transaction.

Walker Jennifer S., who is SVP - Process Improvement at Wright Medical Group, sold 565 shares at $26.06 on May 18, 2015. Following this transaction, the SVP - Process Improvement owned 36,846 shares meaning that the stake was reduced by 1.51% with the 565-share transaction.

Andrews Julie, who is VP Fin. & Chief Acctg. Officer at Wright Medical Group, sold 687 shares at $26.04 on May 18, 2015. Following this transaction, the VP Fin. & Chief Acctg. Officer owned 15,186 shares meaning that the stake was reduced by 4.33% with the 687-share transaction.

Senner Jason R., who is SVP, Chief HR Officer at Wright Medical Group, sold 335 shares at $25.70 on May 18, 2015. Following this transaction, the SVP, Chief HR Officer owned 3,546 shares meaning that the stake was reduced by 8.63% with the 335-share transaction.

The shares most recently traded at $26.06, up $0.36, or 1.38% since the insider transaction. Historical insider transactions for Wright Medical Group go as follows:

  • 4-Week # shares sold: 5,966
  • 12-Week # shares sold: 7,462
  • 24-Week # shares sold: 7,462

The average volume for Wright Medical Group has been 1.1 million shares per day over the past 30 days. Wright Medical Group has a market cap of $1.4 billion and is part of the health care sector and health services industry. Shares are down 2.57% year-to-date as of the close of trading on Monday.

Wright Medical Group, Inc., a specialty orthopaedic company, provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients' lifestyles worldwide. Currently, there are 7 analysts who rate Wright Medical Group a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WMGI - FREE

TheStreet Quant Ratings rates Wright Medical Group as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity, generally disappointing historical performance in the stock itself and generally high debt management risk. Get the full Wright Medical Group Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Online Retailers Hit by Supreme Court Ruling Requiring Sales Tax Collection

Online Retailers Hit by Supreme Court Ruling Requiring Sales Tax Collection

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins

Stocks Tumble as Dow Heads for Eighth Straight Drop

Stocks Tumble as Dow Heads for Eighth Straight Drop

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

Video: Jim Cramer on Netflix, Disney, Intel, Micron and Goldman Sachs

Video: Jim Cramer on Netflix, Disney, Intel, Micron and Goldman Sachs